Blog

Insights-Driven Trial Planning – Better Decisions for Better Trial Outcomes

This is Part #2 of a blog series describing how disruptive innovation technologies such as Saama’s Life Science Analytics Cloud is enabling the Pharma industry to bend its clinical development cost curve sharply downwards while bringing cures to patients sooner.  This blog, co-authored by Nekzad Shroff  and Amit Gulwadi , explains the ROI benefits of improved trial planning decisions…

Read More

Clinical Trial Excellence for Tomorrow and Beyond Blog Series Concluding Post

In September, Saama initiated a novel blog series, Clinical Trial Excellence for Tomorrow and Beyond, which proudly showcased the experience and expertise of the six newest members of Saama’s Clinical Board of Advisors. These stellar professionals offered insightful commentary and informed predictions about the current and future role AI-enabled data analytics will play in the life science industry’s ongoing clinical development efforts.

Read More

Saama to the Rescue: Trial Manager

Saama continues our new blog series, “Saama to the Rescue,” in which we profile common, real-life challenges encountered by various levels of clinical trial leadership every day, and how Saama solutions can pave the way for more efficient and effective clinical operations. We recognize that, in any clinical study, trial leadership at every level have…

Read More

Cost Considerations: Data Analytics for Biotech Clinical Trials

This week concludes Saama’s Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which has been authored by one of our six new Clinical Board of Advisor members. In this final post, Jay Kaminski  , Chief Operating Officer at Celularity and former Senior Vice President of Global Clinical Research & Development Operations at Celgene Corporation, explores the challenges…

Read More

Saama to the Rescue: Central Monitor

Saama continues our new blog series, “Saama to the Rescue,” in which we profile common, real-life challenges encountered by various levels of clinical trial leadership every day, and how Saama solutions can pave the way for more efficient and effective clinical operations. We recognize that, in any clinical study, trial leadership at every level have…

Read More

Saama to the Rescue: Data Manager

Saama continues our new blog series, “Saama to the Rescue,” in which we profile common, real-life challenges encountered by various levels of clinical trial leadership every day, and how Saama solutions can pave the way for more efficient and effective clinical operations. We recognize that, in any clinical study, trial leadership at every level have…

Read More

Cost Considerations: Critical for Clinical Trials

Saama is pleased to continue our Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which will be authored by one of our six new Clinical Board of Advisor members. This week, John Fox, Vice President of Global Payroll at Johnson & Johnson and Vice President of Information Technology at Pharmaceuticals Group, addresses the financial considerations that…

Read More

Bring a drug to market 1 year early, save $85M along the way

This is Part #1 of a blog series describing how disruptive innovation technologies such as Saama’s Life Science Analytics Cloud is enabling the Pharma industry to bend its clinical development cost curve sharply downwards while bringing cures to patients sooner. Co-authored by Nekzad Shroff,  Vice President for Business Consulting and Enablement and Amit Gulwadi,  Senior Vice…

Read More

Saama to the Rescue: The Clinical Trial Manager’s Trials

Saama continues our new blog series, “Saama to the Rescue,” in which we profile common, real-life challenges encountered by various levels of clinical trial leadership every day, and how Saama solutions can pave the way for more efficient and effective clinical operations. We recognize that, in any clinical study, trial leadership at every level have…

Read More

Streamlining Clinical Trials for the Future

Saama is pleased to continue our Clinical Trial Excellence for Tomorrow and Beyond blog series, each installment of which will be authored by one of our six new Clinical Board of Advisor members. This week, Scot Harper, Ph.D., President of SLH Group, a life sciences consulting company and previously CEO of Novartis Clinical Operations, address some steps life science industry clinical…

Read More

Related Posts